Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells

被引:0
|
作者
Hodin, RA [1 ]
Meng, SF [1 ]
Archer, S [1 ]
Tang, R [1 ]
机构
[1] HARVARD DIGEST DIS CTR,BOSTON,MA 02215
来源
CELL GROWTH & DIFFERENTIATION | 1996年 / 7卷 / 05期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Enterocyte differentiation occurs at the crypt-villus junction through the transcriptional activation of cell-specific genes, including the brush-border enzyme intestinal alkaline phosphatase (IAP) and the microvillar structural protein, villin. Based upon previous in vivo studies demonstrating that IAP and villin are differentially affected by alterations in epithelial growth state, we examined the regulation of these two genes in an in vitro model of enterocyte differentiation. HT-29 cells were maintained in DMEM + 10% FCS and treated with sodium butyrate to induce enterocyte differentiation. Cell count and [H-3]thymidine measurements confirm that sodium butyrate causes a marked decrease in cellular growth state, consistent with the differentiation process. Northern blot analyses revealed time- and dose-dependent increases (P < 0.001) in steady-state IAP and villin mRNA levels. The increases in both IAP and villin expression were dependent upon the presence of one or more newly synthesized proteins. Post-confluence and serum starvation were used to cause cell cycle withdrawal prior to the differentiation process. As predicted from our previous in vivo data, villin expression was unaffected by changes in cellular growth state, whereas IAP expression was dramatically diminished under hypoproliferative conditions. We conclude that early withdrawal from the cell cycle alters the course of enterocyte differentiation, specifically decreasing IAP expression.
引用
收藏
页码:647 / 653
页数:7
相关论文
共 50 条
  • [1] CELLULAR GROWTH-STATE DIFFERENTIALLY REGULATES ENTEROCYTE GENE-EXPRESSION IN HT-29 CELLS
    HODIN, RA
    MENG, S
    NGUYEN, D
    GASTROENTEROLOGY, 1994, 106 (04) : A238 - A238
  • [2] Proteome analysis of butyrate-treated human colon cancer cells (HT-29)
    Tan, S
    Seow, TK
    Liang, RCMY
    Koh, S
    Lee, CPC
    Chung, MCM
    Hooi, SC
    INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (04) : 523 - 531
  • [3] EXPRESSION AND FUNCTION OF A PEPTIDE-YY Y1 RECEPTOR IN BUTYRATE-TREATED HT-29 CELLS
    MANNON, PJ
    MERVIN, SJ
    SHERIFFCARTER, KD
    GASTROENTEROLOGY, 1994, 106 (04) : A825 - A825
  • [4] Comparative cellular effects of butyrate and Trichostatin A in HT-29 cells
    Siavoshian, S
    Segain, JP
    Kornprobst, M
    Cherbut, C
    Galmiche, JP
    Blottiere, HM
    GUT, 1997, 41 : A2 - A2
  • [5] Effects of increased cellular zinc levels on gene and protein expression in HT-29 cells
    Kindermann, B
    Döring, F
    Fuchs, D
    Pfaffl, MW
    Daniel, H
    BIOMETALS, 2005, 18 (03) : 243 - 253
  • [6] Effects of increased cellular zinc levels on gene and protein expression in HT-29 cells
    Birgit Kindermann
    Frank Döring
    Dagmar Fuchs
    Michael W. Pfaffl
    Hannelore Daniel
    Biometals, 2005, 18 : 243 - 253
  • [7] BUTYRATE RAPIDLY INDUCES GROWTH-INHIBITION AND DIFFERENTIATION IN HT-29 CELLS
    BARNARD, JA
    WARWICK, G
    CELL GROWTH & DIFFERENTIATION, 1993, 4 (06): : 495 - 501
  • [8] Integrative analysis of DNA methylation and gene expression in butyrate-treated CHO cells
    Wippermann, Anna
    Rupp, Oliver
    Brinkrolf, Karina
    Hoffrogge, Raimund
    Noll, Thomas
    JOURNAL OF BIOTECHNOLOGY, 2017, 257 : 150 - 161
  • [9] The C-terminal Src kinase (CSK) is widely expressed, active in HT-29 cells that contain activated Src, and its expression is downregulated in butyrate-treated SW620 cells
    Li, SL
    Ke, S
    Budde, RJA
    CELL BIOLOGY INTERNATIONAL, 1996, 20 (11) : 723 - 729
  • [10] Modulation of CFTR gene expression in HT-29 cells by extracellular hyperosmolarity
    Baudouin-Legros, M
    Brouillard, F
    Cougnon, M
    Tondelier, D
    Leclerc, T
    Edelman, A
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 278 (01): : C49 - C56